Kodelak Broncho tablets 20

Country

Russia

INN

Ambroxol+Sodium Glycyrrhizinate+Thyme Creeping Herb Extract

Composition

Active substances: ambroxol hydrochloride - 20 mg sodium glycyrrhizinate - 30 mg dry extract of thermopsis - 10 mg sodium bicarbonate - 200 mg

Excipients: potato starch, microcrystalline cellulose, povidone K25 (collidone K25), talc, stearic acid, sodium carboxymethyl starch (sodium starch glycolate, primojel).

Pharmacological properties

A combined drug for the treatment of cough, has a musolytic and expectorant effect, and also has anti-inflammatory activity. Action Kodelak ^® The broncho is due to the pharmacological properties of its components.

Ambroxol has a secretomotor, secretolytic and expectorant effect, normalizes the disturbed ratio of serous and mucous components of sputum, increases the secretion of surfactant in the alveoli. Reduces the viscosity of sputum and promotes its release.

Glycyrrheat (glycyrrhizoic acid and its salts) has anti-inflammatory and antiviral effects. It has a cytoprotective effect due to antioxidant and membrane-stabilizing activity. Potentiases the action of endogenous GCS, providing anti-inflammatory and antiallergic effects. Due to the pronounced anti-inflammatory activity, it helps to reduce the inflammatory process in the respiratory tract.

Thermopsis extract has an expectorant effect, exerting a moderate irritating effect on the receptors of the gastric mucosa, reflexively increases the secretion of the bronchial glands.

Sodium bicarbonate shifts the pH of bronchial mucus to the alkaline side, reduces the viscosity of sputum, stimulates the motor function of the ciliac epithelium and bronchioles.

Indications for use

Disease airways with difficulty in sputum discharge:

• acute and chronic bronchitis;
• pneumonia;
• COPD;
• bronchiectasis.

Contraindications

• pregnancy;
• lactation period;
• children's age up to 12 years;
• hypersensitivity to the components of the drug.

With caution should be used in patients with hepatic and / or renal failure, peptic ulcer of the stomach and duodenum, with bronchial asthma.

Use in pregnancy and lactation

Preparation Kodelak ^® Broncho is contraindicated during pregnancy and lactation (breastfeeding).

Use in case of impaired liver function

Caution should be used in patients with hepatic and / or renal failure.

Use in renal impairment

Caution should be used in patients with hepatic and / or renal failure.

Use in children

Contraindication: children under 12 years of age.

Special instructions

Do not combine with antitussive drugs

Dosage and Administration

The drug should be taken orally during meals.

Adults and children over 12 years of age are prescribed 1 tablet 3 times / day.

It is not recommended to use the drug for more than 4-5 days without a doctor's prescription.

Overdose

Symptoms: nausea, vomiting, diarrhea, dyspepsia.

Treatment: gastric lavage is advisable in the first 1-2 hours after taking the drug; conducting symptomatic therapy.

Side effects

From the side of the central nervous system: rarely - weakness, headache.

From the digestive system: rarely - diarrhea, dry mouth, constipation; with prolonged use in high doses - gastralgia, nausea, vomiting.

From the respiratory system: rarely - dryness of the mucous membrane of the respiratory tract, rhinorrhea.

Other: rarely - dysuria, exanthema, allergic reactions.

Storage conditions

The drug should be stored out of the reach of children, protected from light at a temperature not exceeding 25 ° C.